丽珠集团新北江制药

Livzon Group Xinbeijiang Pharmaceutical is a prominent Chinese pharmaceutical company and a core subsidiary of the Livzon Pharmaceutical Group. Based in Qingyuan, Guangdong, the company specializes in the research, development, and large-scale manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms, particularly those derived from microbial fermentation. Its extensive product portfolio features leading cardiovascular therapies such as lovastatin and pravastatin, as well as the anti-diabetic agent acarbose and immunosuppressants like mycophenolate mofetil. The company is recognized as a national high-tech enterprise and maintains manufacturing facilities that adhere to international standards, including US FDA and EU GMP certifications. By leveraging its advanced fermentation and synthesis platforms, Livzon Group Xinbeijiang Pharmaceutical serves as a critical supplier for both the domestic Chinese market and international pharmaceutical supply chains.